News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
280,039 Results
Type
Article (14566)
Company Profile (57)
Press Release (265413)
Multimedia
Podcasts (74)
Webinars (13)
Section
Business (101357)
Career Advice (468)
Deals (15485)
Drug Delivery (86)
Drug Development (36917)
Employer Resources (50)
FDA (6441)
Job Trends (6263)
News (151271)
Policy (14192)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (458)
Accelerated approval (27)
ADA (11)
Adcomms (9)
Allergies (105)
Alliances (23376)
ALS (76)
Alzheimer's disease (554)
Antibody-drug conjugate (ADC) (187)
Approvals (6804)
Artificial intelligence (302)
ASCO (113)
Autoimmune disease (87)
Automation (22)
Bankruptcy (152)
Best Places to Work (4383)
BIO (24)
BIOSECURE Act (9)
Biosimilars (171)
BioSpace Insights (66)
Biotechnology (27)
Bladder cancer (55)
Brain cancer (41)
Breast cancer (221)
Cancer (1845)
Cardiovascular disease (213)
Career advice (423)
Career pathing (15)
CAR-T (69)
CDC (8)
Cell therapy (209)
Cervical cancer (20)
Clinical research (32880)
Collaboration (1032)
Commercialization (3)
Company closure (2)
Compensation (435)
Complete response letters (51)
COVID-19 (790)
CRISPR (56)
C-suite (719)
Cystic fibrosis (65)
Data (2716)
Decentralized trials (1)
Denatured (19)
Depression (63)
Dermatology (17)
Diabetes (172)
Diagnostics (1496)
Digital health (17)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (189)
Drug pricing (122)
Drug shortages (15)
Duchenne muscular dystrophy (109)
Earnings (34639)
Editorial (25)
Employer branding (4)
Employer resources (46)
Events (40130)
Executive appointments (651)
FDA (7979)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (597)
Gene editing (90)
Generative AI (32)
Gene therapy (210)
GLP-1 (501)
Government (1440)
Grass and pollen (4)
Guidances (177)
Healthcare (3652)
Hematology (66)
HIV (21)
Huntington's disease (13)
IgA nephropathy (61)
Immunology and inflammation (94)
Immuno-oncology (34)
Indications (110)
Infectious disease (892)
Inflammatory bowel disease (89)
Inflation Reduction Act (7)
Influenza (29)
Intellectual property (152)
Interviews (59)
IPO (5946)
IRA (33)
Job creations (2061)
Job search strategy (375)
JPM (29)
Kidney cancer (15)
Labor market (39)
Layoffs (216)
Leadership (11)
Legal (3456)
Licensing (6)
Liver cancer (27)
Longevity (11)
Lung cancer (258)
Lymphoma (168)
Machine learning (16)
Management (17)
Manufacturing (631)
Marketing (7)
MASH (93)
Medical affairs (1)
Medical device (1322)
Medtech (1344)
Mergers & acquisitions (10112)
Metabolic disorders (590)
mRNA (66)
Multiple sclerosis (66)
NASH (15)
Neurodegenerative disease (126)
Neuropsychiatric disorders (51)
Neuroscience (1134)
Neurotech (1)
NextGen: Class of 2026 (1588)
Non-profit (611)
Now hiring (24)
Obesity (304)
Opinion (154)
Ovarian cancer (69)
Pain (141)
Pancreatic cancer (78)
Parkinson's disease (118)
Partnered (12)
Patents (306)
Patient recruitment (208)
Peanut (15)
People (30438)
Pharmaceutical (33)
Pharmacy benefit managers (19)
Phase 1 (8521)
Phase 2 (13866)
Phase 3 (12551)
Pipeline (4073)
Policy (153)
Postmarket research (1408)
Preclinical (3432)
Press Release (25)
Prostate cancer (123)
Psychedelics (27)
Radiopharmaceuticals (168)
Rare diseases (523)
Real estate (2668)
Recruiting (19)
Regulatory (11641)
Reports (19)
Research institute (583)
Resumes & cover letters (55)
Rett syndrome (12)
RNA editing (9)
RSV (26)
Schizophrenia (89)
Series A (119)
Series B (69)
Service/supplier (1)
Sickle cell disease (62)
Special edition (11)
Spinal muscular atrophy (85)
Sponsored (11)
Startups (1658)
State (2)
Stomach cancer (6)
Supply chain (69)
Tariffs (71)
The Weekly (53)
Vaccines (287)
Venture capital (44)
Weight loss (175)
Women's health (53)
Worklife (4)
Date
Today (8)
Last 7 days (232)
Last 30 days (852)
Last 365 days (10471)
2026 (6742)
2025 (10753)
2024 (12505)
2023 (14282)
2022 (19600)
2021 (20101)
2020 (19044)
2019 (14889)
2018 (11713)
2017 (13899)
2016 (13129)
2015 (15487)
2014 (12443)
2013 (10611)
2012 (11414)
2011 (11965)
2010 (10933)
Location
Africa (325)
Alabama (23)
Alaska (1)
Arizona (95)
Arkansas (4)
Asia (21395)
Australia (2761)
California (4209)
Canada (1908)
China (813)
Colorado (184)
Connecticut (170)
Delaware (177)
Europe (42288)
Florida (806)
Georgia (81)
Hawaii (2)
Idaho (11)
Illinois (487)
India (82)
Indiana (331)
Iowa (2)
Japan (380)
Kansas (89)
Kentucky (21)
Louisiana (7)
Maine (2)
Maryland (531)
Massachusetts (3396)
Michigan (55)
Minnesota (219)
Mississippi (1)
Missouri (41)
Montana (9)
Nebraska (8)
Nevada (20)
New Hampshire (9)
New Jersey (1859)
New Mexico (7)
New York (1202)
North Carolina (782)
North Dakota (2)
Northern California (1997)
Ohio (98)
Oklahoma (5)
Oregon (16)
Pennsylvania (907)
Puerto Rico (18)
Rhode Island (18)
South America (510)
South Carolina (12)
Southern California (1879)
Tennessee (78)
Texas (589)
United States (16631)
Utah (69)
Vermont (1)
Virginia (219)
Washington D.C. (42)
Washington State (309)
West Virginia (1)
Wisconsin (60)
Wyoming (1)
280,039 Results for "eton pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 13, 2026
·
22 min read
Press Releases
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
August 3, 2026
·
1 min read
Press Releases
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
May 13, 2026
·
1 min read
Press Releases
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
May 14, 2026
·
20 min read
Press Releases
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
August 5, 2026
·
8 min read
Press Releases
Eton Pharmaceuticals Announces CFO Succession Plan
April 16, 2026
·
2 min read
Press Releases
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
May 1, 2026
·
6 min read
Press Releases
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
May 4, 2026
·
1 min read
Press Releases
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
April 27, 2026
·
6 min read
Press Releases
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
May 20, 2026
·
7 min read
1 of 28,004
Next
